Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Rifampin on Istradefylline PK
NCT02174250Phase 1Completed
- Sponsor
- Kyowa Kirin
- Start
- Jun 2014
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of Istradefylline in Parkinson's disease (PD) (2 arms), sponsored by Kyowa Kirin. Primary endpoints: Area under the concentration-time curve from time zero to infinity and Observed maximum plasma concentration. Started Jun 2014; status: completed.
02
Drugs
Istradefylline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02174250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02174250.